41
Growth Score
pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
376901
Long Grove Pharmaceuticals is a pharmaceutical company that manufactures pharmaceutical products.
About the Company
Long Grove Pharmaceuticals is a specialty pharmaceutical company that focuses on the development and manufacturing of complex generics, including injectables and topical products. The company is committed to delivering differentiated pharmaceuticals designed to ease operational burdens in healthcare. Their product portfolio includes Carboprost
Tromethamine Injection, USP, an AP rated, TAA compliant product made in Canada. The company also announced the strategic in-licensing of Norepinephrine in 0.9% Sodium Chloride premix formulation. The leadership team, with decades of executive expertise within healthcare companies, steers the next-generation generic pharmaceuticals.
